Kestra Medical Technologies (KMTS|$765.6M) - 2025 Q4 & Full Year Earnings Analysis

Описание: #KMTS Kestra Medical Technologies 2025 Q4 & Full Year Earnings: Kestra Medical Technologies reported significant revenue growth and margin improvements in Q4 and FY25, despite missing EPS expectations.

Revenue: $17.2 million in Q4, $59.8 million in FY25

Adj. EPS: -$2.21 vs. forecast -$0.54 (5 analysts)

Gross Margin: 44.3% in Q4, 40.5% in FY25

FY26 Revenue Guidance: $85 million

"We capped an exciting year for Kestra with a very strong finish to our fiscal 2025. This quarter’s financial results reflect accelerating demand for our best-in-class cardiac recovery system as we continue to benefit from heightened prescriber awareness and the overwhelmingly positive experience patients are having with the ASSURE® system," said Brian Webster, President and CEO.

If you enjoyed this video, please like, subscribe, and hit the notification bell to stay updated with our latest stock analysis and market insights. Leave a comment below with your thoughts on the video, and any other stocks you'd like us to cover.

Check out our latest videos on more earnings:

#FULT Fulton Financial 2025 Q2 Earnings:    • Fulton Financial (FULT|$3.5B) - 2025 Q2 Ea...  

#OMC Omnicom 2025 Q2 Earnings:    • Omnicom (OMC|$14.2B) - 2025 Q2 Earnings An...  

#HWC Hancock Whitney 2025 Q2 Earnings:    • Hancock Whitney (HWC|$5.1B) - 2025 Q2 Earn...  

#ANGO AngioDynamics 2025 Q4 & Full Year Earnings:    • AngioDynamics (ANGO|$378.5M) - 2025 Q4 & F...  

#ACI Albertsons 2025 Q1 Earnings:    • Albertsons (ACI|$12.8B) - 2025 Q1 Earnings...